| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 74476 |
丙酸氯倍他索脂质体,Clobetasol Propionate Liposome |
88 |
axc |
2024-12-25 |
| 74477 |
cas:146651-71-0，N-Boc-Tris，抗体偶联药物 |
99 |
h |
2024-12-25 |
| 74478 |
BocNH-PEG2-CH2CH2NH2 cas:153086-78-3 |
109 |
zyl |
2024-12-25 |
| 74479 |
Lenvatinib Liposome Lenvatinib，仑伐替尼脂质体 |
120 |
axc |
2024-12-25 |
| 74480 |
Ald-Ph-amido-PEG4-C2-acid，1309460-27-2，抗体- 药物偶联物 |
92 |
hyy |
2024-12-25 |
| 74481 |
mPEG23-OCH2CH2COOH的性质与用途 |
86 |
wyh |
2024-12-25 |
| 74482 |
CBZ-NH-PEG3-CH2CH2COOH cas:1310327-18-4 |
99 |
zyl |
2024-12-25 |
| 74483 |
cas:1821017-46-2，Methyltetrazine-Sulfo-NHS ester |
107 |
h |
2024-12-25 |
| 74484 |
盐酸西替利嗪脂质体，Cetirizine Hydrochloride Liposome |
111 |
axc |
2024-12-25 |
| 74485 |
cas:124529-64-2，tert-butyl 6-(2,5-dioxo-2H-pyrrol-1(5H)-yl)hexylcarbamate |
108 |
h |
2024-12-25 |
| 74486 |
淫羊藿素脂质体(聚乙二醇化)，Icaritin Liposome (PEGylated) |
157 |
axc |
2024-12-25 |
| 74487 |
cas:146474-00-2，1-(2-Aminoethyl)-1H-pyrrole-2,5-dione TFA salt |
115 |
h |
2024-12-25 |
| 74488 |
CBZ-NH-PEG3-CH2COOH cas:462100-05-6 |
122 |
zyl |
2024-12-25 |
| 74489 |
Ald-Ph-amido-PEG2，1061569-06-9，ADC试剂 |
87 |
hyy |
2024-12-25 |
| 74490 |
mPEG24-Hydrazide，甲氧基二十四聚乙二醇酰肼 |
166 |
wyh |
2024-12-25 |
| 74491 |
双氢青蒿素脂质体，Dihydroartemisinin Liposome |
99 |
axc |
2024-12-25 |
| 74492 |
cas:7423-55-4，3-Maleimidopropionic acid，抗体偶联药物 |
194 |
h |
2024-12-25 |
| 74493 |
mPEG11-Hydrazide，甲氧基十一聚乙二醇-酰肼 |
90 |
wyh |
2024-12-25 |
| 74494 |
青蒿素脂质体，Artemisinin Liposome |
154 |
axc |
2024-12-25 |
| 74495 |
cas:2054345-67-2，N3-tris(ethylenoxy)-L-alanine TFA Salt |
101 |
h |
2024-12-25 |
| 74496 |
cas:1155811-37-2 H2N-PEG1-CH2COOtBu的结构式 |
152 |
zyl |
2024-12-25 |
| 74497 |
Ald-Ph-amido-PEG4-C2-NHS ester，1353011-74-1，抗体- 药物偶联物 |
101 |
hyy |
2024-12-25 |
| 74498 |
cas:1398044-54-6，2-t-Butoxycarbonylamino-1,3-bis(carboxyethoxy)propane |
123 |
h |
2024-12-25 |
| 74499 |
2-（2-羟基-5-氨基苯基）苯并咪唑（NH2-HBI） |
116 |
WYQ |
2024-12-25 |
| 74500 |
枸橼酸托法替尼脂质体，Tofacitinib Citrate Liposome |
177 |
axc |
2024-12-25 |
| 74501 |
cas:2028284-70-8，Sulfo DBCO-amine，抗体偶联药物 |
85 |
h |
2024-12-25 |
| 74502 |
四苯基卟啉四磺酸钠（TPPSNa） |
130 |
WYQ |
2024-12-25 |
| 74503 |
DBCO-CONH-PEG12-CH2CH2COONHS的结构式 |
92 |
zyl |
2024-12-25 |
| 74504 |
cas:1353016-70-2，DBCO-acid，抗体偶联药物 |
126 |
h |
2024-12-25 |
| 74505 |
cas:98604-88-7，bis(2,5-dioxopyrrolidin-1-yl) 4,4'-disulfanediyldibutanoate |
161 |
h |
2024-12-25 |
| 74506 |
四-[3-甲氧基-4-(N-咔唑)正丁氧苯基]卟啉（4C4-TPP） |
128 |
WYQ |
2024-12-25 |
| 74507 |
Ald-Ph-amido-PEG3-C1-Boc，1007215-94-2，ADC试剂 |
97 |
hyy |
2024-12-25 |
| 74508 |
mPEG3-Hydrazide，甲氧基三聚乙二醇-酰肼 |
163 |
wyh |
2024-12-25 |
| 74509 |
DBCO-CONH-PEG12-CH2CH2COOH的介绍 |
90 |
zyl |
2024-12-25 |
| 74510 |
cas:1324007-10-4，2,3,4,5,6-pentafluorophenyl 1-[(4-formylphenyl)formamido]-3,6,9,12-tetraoxapentadecan-15-oate |
100 |
h |
2024-12-25 |
| 74511 |
唑来膦酸脂质体，Zoledronic Acid Liposome |
170 |
axc |
2024-12-25 |
| 74512 |
不对称酰胺基卟啉5-(4-棕榈酸酰亚胺基)苯基-10,15,20-三苯基卟啉（PITPPH2） |
123 |
WYQ |
2024-12-25 |
| 74513 |
盐酸拓扑替康脂质体(聚乙二醇化)，Topotecan Hydrochloride Liposome (PEGylated) |
150 |
axc |
2024-12-25 |
| 74514 |
DBCO-CONH-PEG4-CH2CH2COONHS的结构式 |
114 |
zyl |
2024-12-25 |
| 74515 |
perfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10,13-tetraoxa-4-azahexadecan-16-oate |
95 |
h |
2024-12-25 |
| 74516 |
他莫昔芬脂质体，Tamoxifen Liposome |
115 |
axc |
2024-12-25 |
| 74517 |
2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate |
118 |
h |
2024-12-25 |
| 74518 |
Methyltetrazine-CH2NHCO-PEG9-Biotin |
98 |
zyl |
2024-12-25 |
| 74519 |
藤黄酸脂质体，Gambogic Acid Liposome |
92 |
axc |
2024-12-25 |
| 74520 |
cas:1006592-59-1，2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate |
98 |
h |
2024-12-25 |
齐岳微信公众号
官方微信
库存查询